Ophthalmological Disorders in Dominant Spinal-cerebellar Ataxias — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Ophthalmological Disorders in Dominant Spinal-cerebellar Ataxias — Stella

Home/Spinocerebellar Ataxia/

View on ClinicalTrials.gov

Recruiting

Back to Spinocerebellar Ataxia trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

France

CHU Montpellier - Hôpital Gui de Chauliac, Montpellier, Hérault

Key details

Sponsor

University Hospital, Montpellier

Enrollment target

~60 participants

Started

October 2025

Primary completion

October 2027

Age range

18 Years – 80 Years

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.